NeuroScientific Biopharmaceuticals Limited Stock
Equities
NSB
AU0000012973
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.044 AUD | 0.00% | -2.22% | 0.00% |
Sales 2022 | - | Sales 2023 | 4.95M 3.3M | Capitalization | 11.48M 7.65M |
---|---|---|---|---|---|
Net income 2022 | -10M -6.66M | Net income 2023 | -1M -666K | EV / Sales 2022 | - |
Net cash position 2022 | 7.22M 4.81M | Net cash position 2023 | 4.91M 3.27M | EV / Sales 2023 | 1.33 x |
P/E ratio 2022 |
-2.47
x | P/E ratio 2023 |
-10.7
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 65.16% |
1 week | -2.22% | ||
Current month | -8.33% | ||
1 month | -15.38% | ||
3 months | +22.22% | ||
6 months | -38.03% |
Managers | Title | Age | Since |
---|---|---|---|
Simon Scott
CTO | Chief Tech/Sci/R&D Officer | - | 22-03-31 |
Dougal Thring
COO | Chief Operating Officer | - | 21-03-30 |
Anton Uvarov
BRD | Director/Board Member | - | 17-09-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Anton Uvarov
BRD | Director/Board Member | - | 17-09-28 |
Chairman | - | Nov. 16 | |
Tony Keating
BRD | Director/Board Member | - | Dec. 04 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-22 | 0.044 | 0.00% | 79 000 |
24-05-21 | 0.044 | -2.22% | 110,443 |
24-05-20 | 0.045 | -2.17% | 31,047 |
24-05-17 | 0.046 | 0.00% | 10,168 |
24-05-16 | 0.046 | +2.22% | 33,652 |
Delayed Quote Australian S.E., May 22, 2024 at 02:10 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
0.00% | 4.24M | |
+44.48% | 55.07B | |
+43.57% | 40.22B | |
-0.86% | 41.79B | |
-7.59% | 28.17B | |
+12.30% | 26.28B | |
-21.83% | 18.93B | |
+7.15% | 13.03B | |
+29.40% | 12.26B | |
+25.15% | 12.21B |
- Stock Market
- Equities
- NSB Stock